View in EDS HTML Full Text PDF Full Text

NAD pool as an antitumor target against cancer stem cells in head and neck cancer.

Saved in:
Bibliographic Details
Title: NAD pool as an antitumor target against cancer stem cells in head and neck cancer.
Authors: Navas LE; Instituto de Biomedicina de Sevilla (IBIS)/HUVR/CSIC, Hospital Universitario Virgen del Rocío, Ed. IBIS, Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Avda. Manuel Siurot S/N, 41013, Seville, Spain.; CIBER de Cancer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Blanco-Alcaina E; Instituto de Biomedicina de Sevilla (IBIS)/HUVR/CSIC, Hospital Universitario Virgen del Rocío, Ed. IBIS, Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Avda. Manuel Siurot S/N, 41013, Seville, Spain.; CIBER de Cancer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Suarez-Martinez E; Instituto de Biomedicina de Sevilla (IBIS)/HUVR/CSIC, Hospital Universitario Virgen del Rocío, Ed. IBIS, Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Avda. Manuel Siurot S/N, 41013, Seville, Spain.; CIBER de Cancer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Verdugo-Sivianes EM; Instituto de Biomedicina de Sevilla (IBIS)/HUVR/CSIC, Hospital Universitario Virgen del Rocío, Ed. IBIS, Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Avda. Manuel Siurot S/N, 41013, Seville, Spain.; CIBER de Cancer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Espinosa-Sanchez A; Instituto de Biomedicina de Sevilla (IBIS)/HUVR/CSIC, Hospital Universitario Virgen del Rocío, Ed. IBIS, Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Avda. Manuel Siurot S/N, 41013, Seville, Spain.; CIBER de Cancer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Sanchez-Diaz L; Instituto de Biomedicina de Sevilla (IBIS)/HUVR/CSIC, Hospital Universitario Virgen del Rocío, Ed. IBIS, Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Avda. Manuel Siurot S/N, 41013, Seville, Spain.; CIBER de Cancer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Dominguez-Medina E; BioFarma-USEF Research Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Santiago de Compostela, Spain., Fernandez-Rozadilla C; Grupo de Medicina Xenómica (USC), Fundación Pública Galega de Medicina Xenómica, Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain., Carracedo A; Grupo de Medicina Xenómica (USC), Fundación Pública Galega de Medicina Xenómica, Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain.; CIBER de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain., Wu LE; School of Medical Sciences, UNSW Sydney, Sydney, NSW, Australia., Carnero A; Instituto de Biomedicina de Sevilla (IBIS)/HUVR/CSIC, Hospital Universitario Virgen del Rocío, Ed. IBIS, Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Avda. Manuel Siurot S/N, 41013, Seville, Spain. acarnero-ibis@us.es.; CIBER de Cancer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain. acarnero-ibis@us.es.
Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Mar 03; Vol. 42 (1), pp. 55. Date of Electronic Publication: 2023 Mar 03.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36864434
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: NAD pool as an antitumor target against cancer stem cells in head and neck cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Navas+LE%22">Navas LE</searchLink>; Instituto de Biomedicina de Sevilla (IBIS)/HUVR/CSIC, Hospital Universitario Virgen del Rocío, Ed. IBIS, Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Avda. Manuel Siurot S/N, 41013, Seville, Spain.; CIBER de Cancer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Blanco-Alcaina+E%22">Blanco-Alcaina E</searchLink>; Instituto de Biomedicina de Sevilla (IBIS)/HUVR/CSIC, Hospital Universitario Virgen del Rocío, Ed. IBIS, Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Avda. Manuel Siurot S/N, 41013, Seville, Spain.; CIBER de Cancer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Suarez-Martinez+E%22">Suarez-Martinez E</searchLink>; Instituto de Biomedicina de Sevilla (IBIS)/HUVR/CSIC, Hospital Universitario Virgen del Rocío, Ed. IBIS, Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Avda. Manuel Siurot S/N, 41013, Seville, Spain.; CIBER de Cancer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Verdugo-Sivianes+EM%22">Verdugo-Sivianes EM</searchLink>; Instituto de Biomedicina de Sevilla (IBIS)/HUVR/CSIC, Hospital Universitario Virgen del Rocío, Ed. IBIS, Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Avda. Manuel Siurot S/N, 41013, Seville, Spain.; CIBER de Cancer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Espinosa-Sanchez+A%22">Espinosa-Sanchez A</searchLink>; Instituto de Biomedicina de Sevilla (IBIS)/HUVR/CSIC, Hospital Universitario Virgen del Rocío, Ed. IBIS, Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Avda. Manuel Siurot S/N, 41013, Seville, Spain.; CIBER de Cancer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Sanchez-Diaz+L%22">Sanchez-Diaz L</searchLink>; Instituto de Biomedicina de Sevilla (IBIS)/HUVR/CSIC, Hospital Universitario Virgen del Rocío, Ed. IBIS, Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Avda. Manuel Siurot S/N, 41013, Seville, Spain.; CIBER de Cancer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Dominguez-Medina+E%22">Dominguez-Medina E</searchLink>; BioFarma-USEF Research Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Santiago de Compostela, Spain.<br /><searchLink fieldCode="AU" term="%22Fernandez-Rozadilla+C%22">Fernandez-Rozadilla C</searchLink>; Grupo de Medicina Xenómica (USC), Fundación Pública Galega de Medicina Xenómica, Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain.<br /><searchLink fieldCode="AU" term="%22Carracedo+A%22">Carracedo A</searchLink>; Grupo de Medicina Xenómica (USC), Fundación Pública Galega de Medicina Xenómica, Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain.; CIBER de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Wu+LE%22">Wu LE</searchLink>; School of Medical Sciences, UNSW Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Carnero+A%22">Carnero A</searchLink>; Instituto de Biomedicina de Sevilla (IBIS)/HUVR/CSIC, Hospital Universitario Virgen del Rocío, Ed. IBIS, Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Avda. Manuel Siurot S/N, 41013, Seville, Spain. acarnero-ibis@us.es.; CIBER de Cancer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain. acarnero-ibis@us.es.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228308647%22">Journal of experimental & clinical cancer research : CR</searchLink> [J Exp Clin Cancer Res] 2023 Mar 03; Vol. 42 (1), pp. 55. <i>Date of Electronic Publication: </i>2023 Mar 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8308647 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1756-9966 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203929078%22">03929078 </searchLink><i>NLM ISO Abbreviation: </i>J Exp Clin Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36864434
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13046-023-02631-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 55
    Titles:
      – TitleFull: NAD pool as an antitumor target against cancer stem cells in head and neck cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Navas LE
      – PersonEntity:
          Name:
            NameFull: Blanco-Alcaina E
      – PersonEntity:
          Name:
            NameFull: Suarez-Martinez E
      – PersonEntity:
          Name:
            NameFull: Verdugo-Sivianes EM
      – PersonEntity:
          Name:
            NameFull: Espinosa-Sanchez A
      – PersonEntity:
          Name:
            NameFull: Sanchez-Diaz L
      – PersonEntity:
          Name:
            NameFull: Dominguez-Medina E
      – PersonEntity:
          Name:
            NameFull: Fernandez-Rozadilla C
      – PersonEntity:
          Name:
            NameFull: Carracedo A
      – PersonEntity:
          Name:
            NameFull: Wu LE
      – PersonEntity:
          Name:
            NameFull: Carnero A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 03
              Text: 2023 Mar 03
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1756-9966
          Numbering:
            – Type: volume
              Value: 42
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Journal of experimental & clinical cancer research : CR
              Type: main
ResultId 1